Ionis Pharmaceuticals in (ions 1.75 06/15/28)
13F holders, Q1 2026 (March 31)9holders +1
2new positions
1sold out
$2.11avg. 13F price*
At the end of Q1 2026, 9 institutions reported holding Ionis Pharmaceuticals in (ions 1.75 06/15/28) in their 13F filings, up 1 from Q4 2025. 2 opened new positions and 1 sold out. The largest holders were Focus Partners Wealth ($8.0M), Nomura Holdings Inc. ($6.4M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($4.8M).
- Company
- Ionis Pharmaceuticals in (ions 1.75 06/15/28)
- CUSIP
- 462222AF7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $5.7M |
| Exits | 1 | $21K |
All 13F filers, Q4 2025 → Q1 2026: 2,448,657 shares bought and 28,750 shares sold, net +2,419,907 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Focus Partners Wealth | 0.01% | Reduce -0.1% | 5,279,000 | $8.0M |
| Nomura Holdings Inc. | 0.05% | Add +1592.7% | 85,057 | $6.4M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 3,135,000 | $4.8M |
| State of Wisconsin Investment Board | 0.01% | No change | 3,000,000 | $4.5M |
| Ssi Investment Management LLC | 0.29% | New | 2,340,000 | $3.5M |
| Loomis Sayles & Co. L P | 0.00% | New | 28,625 | $2.1M |
| Sei Investments Co. | 0.00% | No change | 105,000 | $158K |
| Boussard & Gavaudan Investment Management LLP | 0.00% | Reduce -92.2% | 1,000 | $2K |
| Oddo BHF Asset Management Sas | 0.00% | No change | 374 | $567 |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 1.75 06/15/28)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 1.75 06/15/28) the manager owns.